SurModics, Inc.

SurModics, Inc.

SurModics, Inc.

Date Founded



9924 West 74th Street, Eden Prairie, MN, 55344, USA

Type of Company


Employees (Worldwide)



Medical Products & Equipment
Hospitals & Patient Services

Company Description

SurModics, Inc. engages in the provision of medical device and in vitro diagnostic technologies to the healthcare industry. It operates through the Medical Device and In Vitro Diagnostics segments. The Medical Device segment designs, develops, and manufactures interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitro Diagnostics segment consists of component products and technologies for diagnostic test kits and biomedical research applications. The company was founded in June 1979 and is headquartered in Eden Prairie, MN.

Contact Data
Trying to get in touch with decision makers at SurModics, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Vice President of Finance & Chief Financial Officer

Senior Vice President, Legal, Human Resources & Information Systems, General Counsel & Secretary

Senior Vice President & Chief Marketing Officer

General Manager-Medical Device

Vice President & General Manager, in Vitro Diagnostics

Chief Operating Officer, Medical Devices

Director of Sales & Market Development

Vice President of Research & Development

Senior Director of Process Development

Board of Directors

Former Chief Financial Officer, Senior Vice President & Head-Investor Relations at MTS Systems Corp.

President & Chief Executive Officer at SurModics, Inc.

Former President, Chief Executive Officer & Director at FastenTech, Inc.

Former Chief Financial Officer at Wright Medical Group NV

Former Chief Operating Officer at Mitralign, Inc.

Paths to SurModics, Inc.
Potential Connections via
Relationship Science
SurModics, Inc.
Owners & Shareholders
Details Hidden

Trigran Investments manages private investment partnerships that seek to maximize total return for each of their respective partners primarily through capital appreciation of their investments. Trigran's primary goal for the partnerships is to produce long-term positive returns well in excess of the Russell 2000 Index. The investment strategy is to invest in, hold, sell and trade equity securities. The primary focus of the partnerships is to invest in a small group of \"buy and hold\" core positions that represent a significant portion of each partnership's assets. Historically, these investments have been mainly in publicly traded companies with total market-cap ions of less than $2 billion, though the Partnerships may invest in small-, medium- or large-cap companies, and such investments may be made for short-term or long-term investment horizons, may be on a leveraged or unleveraged basis, and may consist of long and/or short positions. The partnerships seek to invest in companies trading at sizable discounts to their intrinsic values. In addition, these companies are expected to grow their intrinsic values at reasonable rates over time. A significant portion of each partnership's assets are, and are expected to remain, invested in equity securities of approximately 8 to 12 companies which constitute such partnership's core positions. These investments have anticipated holding periods of three to five years. The firm generally seeks to take long positions in, and options on securities of, companies they believe are undervalued. Trigran may invest in a limited number of securities that are not publicly-traded. In addition, Trigran may from time to time purchase debt securities and use leverage to increase the net assets of the partnerships. The partnerships do not currently have any short positions, do not own shares of any private companies and are not using any leverage.

Details Hidden

Teton Advisors, Inc. (OTC Pink: TETAA) is a multi-strategy investment management company, and is the registered investment adviser to six open-end mutual funds under the TETON Westwood brand. We offer our funds and separately managed accounts to individuals and institutions directly and through third party intermediaries. An affiliate of GAMCO Investors, Inc. (NYSE: GBL), Teton Advisors, Inc. shares the fundamental, research-driven investment philosophy of GAMCO Investors, Inc.

Details Hidden

Murphy Pohlad Asset Management's (MPAM) equity strategy seeks to invest in individually owned common stocks of high quality companies that are managed by leaders they respect, at a price that provides a path to a favorable investment return. These companies exhibit strong market positions supported by an ongoing competitive advantage. Their financial attributes include a strong balance sheet and business operations which generate high levels of cash flow after funding capital expenditures and any acquisition activity. MPAM believes that dividends are an important component of investment return and they focus on owning companies which pay annual dividends to their shareholders.The firm's fixed-income strategy seeks to preserve the investment principal of the fixed-income capital while generating current income in the form of interest. In most interest rate environments, MPAM manages the fixed-income component of a portfolio by building bond ladders comprised of bonds which mature on a regular basis. If they believe that intermediate and long-term interest rates do not offer favorable investment return potential, they will either: (1) build shorter term bond ladders or (2) invest the fixed-income capital in short duration investments, including cash.

Recent Transactions
Details Hidden

SurModics, Inc. purchases NorMedix, Inc.

Details Hidden

SurModics, Inc. purchases Creagh Medical Ltd.

Details Hidden

Evonik Industries AG, RAG-Stiftung purchase Surmodics Pharmaceutical, Inc. from SurModics, Inc.

Insider Transactions
Details Hidden
Transaction Advisors
Legal Advisor

Advised onSurModics, Inc. purchases NorMedix, Inc.


Advised onSurModics, Inc. issued USD Common Stock

Escrow Agent

Advised onSurModics, Inc. purchases Creagh Medical Ltd.

Legal Advisor

Advised onSurModics, Inc. purchases Creagh Medical Ltd.

Legal Advisor

Advised onSurModics, Inc. purchases NorMedix, Inc.

Legal Advisor

Advised onSurModics, Inc. purchases Creagh Medical Ltd.

Advisors & Consultants

Senior Vice President & Chief Financial Officer at Biothera Pharmaceutical, Inc.


Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart and Critical Care. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. Its portfolio includes technologies designed for nonsurgical replacement of heart valves. The Surgical Structural Heart portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The portfolio also includes a diverse line of cardiac surgery systems used during minimally invasive surgical procedures, and cannulae, embolic protection devices and other products used during cardiopulmonary bypass. The Critical Care portfolio products hemodynamic monitoring systems used to measure a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA..

Key Stats and Financials As of 2018
Market Capitalization
Total Enterprise Value
Earnings Per Share
Net Profit
Total Equity
Total Debt
Enterprise Value Sales
Enterprise Value EBITDAOperating
TEVNet Income
Debt TEV
Three Year Compounded Annual Growth Rate Of Revenue
Five Year Compounded Annual Growth Rate Of Revenue
Non-Profit Donations & Grants
Details Hidden

Nexeon MedSystems, Inc. is a medical device company, which focuses on the development, manufacturing, and commercialization of neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform has the potential to provide treatment to patients in several established neurostimulator markets including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other emerging neurostimulator markets. The company was founded by Mark C. Bates and Ralph L. Ballard, III in 2005 and is headquartered in Dallas, TX.

Details Hidden

Aeon Bioscience, Inc. develops drug-eluting polymers and stents that overcome concerns of late stent thrombosis. It addresses the medical challenges for cardiac patients. The company was founded by Christopher E. Banas and Paul Castella on January 29, 2007 and is headquartered in Birmingham, AL.

Details Hidden
InnoCore Technologies BV Holding Companies | Groningen, GR

InnoCore Technologies BV develops drug delivery technologies. It serves the pharmaceutical and medical device industry by developing and manufacturing innovative drug delivery systems that enhance their products. The company was founded by Theodorus Adrianus Cornelius Flipsen and Rob Steendam in 2004 and is headquartered in Groningen, the Netherlands.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by SurModics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of SurModics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and SurModics, Inc..
  • be_ixf; php_sdk; php_sdk_1.4.15